Raras
Buscar doenças, sintomas, genes...
Epilepsia parcial familiar
ORPHA:309PCDT · SUSDOENÇA RARA

Um caso de epilepsia parcial que é causada por uma alteração genética herdada no DNA da pessoa.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Um caso de epilepsia parcial que é causada por uma alteração genética herdada no DNA da pessoa.

Publicações científicas
20 artigos
Último publicado: 2018 Mar
Medicamentos
1 registrados
NALUZOTAN

Tem tratamento?

1 medicamento registrado
Ver detalhes, fases e interações →
NALUZOTAN
🏥
SUS: Cobertura mínimaScore: 30%
PCDT disponível
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
51 sintomas
🦴
Ossos e articulações
6 sintomas
👁️
Olhos
3 sintomas
❤️
Coração
2 sintomas
💪
Músculos
2 sintomas
👂
Ouvidos
2 sintomas

+ 38 sintomas em outras categorias

Características mais comuns

Auras epigástricas
Anormalidade interictal no EEG
Descargas epileptiformes multifocais
Afasia motora
Palidez
Polimicrogiria
108sintomas
Sem dados (108)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 108 características clínicas mais associadas, ordenadas por frequência.

Auras epigástricasEpigastric auras
Anormalidade interictal no EEGInterictal EEG abnormality
Descargas epileptiformes multifocaisMultifocal epileptiform discharges
Afasia motoraMotor aphasia
PalidezPallor

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa8desde 2018
Total histórico20PubMed
Últimos 10 anos1publicações
Pico20181 papers
Linha do tempo
20202018Hoje · 2026🧪 2009Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

19 genes identificados com associação a esta condição.

SCN3ASodium channel protein type 3 subunit alphaDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Pore-forming subunit of Nav1.3, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.

LOCALIZAÇÃO

Cell membraneBasal cell membrane

VIAS BIOLÓGICAS (3)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisationSensory perception of sweet, bitter, and umami (glutamate) taste
MECANISMO DE DOENÇA

Epilepsy, familial focal, with variable foci 4

An autosomal dominant form of epilepsy characterized by focal seizures arising from different cortical regions, including the temporal, frontal, parietal, and occipital lobes. Seizure types commonly include temporal lobe epilepsy, frontal lobe epilepsy, and nocturnal frontal lobe epilepsy. Some patients may have intellectual disability or autism spectrum disorders. Seizure onset usually occurs in the first or second decades, although later onset has been reported, and there is phenotypic variability within families. A subset of patients have structural brain abnormalities. Penetrance of the disorder is incomplete. FFEVF4 is characterized by onset of focal seizures in the first years of life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
13.0 TPM
Cerebelo
11.3 TPM
Hipotálamo
9.3 TPM
Brain Nucleus accumbens basal ganglia
8.5 TPM
Pituitária
8.1 TPM
OUTRAS DOENÇAS (5)
epilepsy, familial focal, with variable foci 4developmental and epileptic encephalopathy, 62genetic developmental and epileptic encephalopathyfamilial focal epilepsy with variable foci
HGNC:10590UniProt:Q9NY46
RELNReelinCandidate gene tested inAltamente restrito
FUNÇÃO

Extracellular matrix serine protease secreted by pioneer neurons that plays a role in layering of neurons in the cerebral cortex and cerebellum by coordinating cell positioning during neurodevelopment. Regulates microtubule function in neurons and neuronal migration. Binding to the extracellular domains of lipoprotein receptors VLDLR and LRP8/APOER2 induces tyrosine phosphorylation of DAB1 and modulation of TAU phosphorylation. Affects migration of sympathetic preganglionic neurons in the spinal

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Reelin signalling pathway
MECANISMO DE DOENÇA

Lissencephaly 2

A classic type lissencephaly associated with ataxia, intellectual disability, seizures and abnormalities of the cerebellum, hippocampus and brainstem.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
161.3 TPM
Cerebelo
101.1 TPM
Nervo tibial
38.5 TPM
Tireoide
4.3 TPM
Hipotálamo
3.8 TPM
OUTRAS DOENÇAS (3)
Norman-Roberts syndromeautosomal dominant epilepsy with auditory featuresfamilial temporal lobe epilepsy 7
HGNC:9957UniProt:P78509
MICAL1[F-actin]-monooxygenase MICAL1Candidate gene tested inTolerante
FUNÇÃO

Monooxygenase that promotes depolymerization of F-actin by mediating oxidation of specific methionine residues on actin to form methionine-sulfoxide, resulting in actin filament disassembly and preventing repolymerization (PubMed:29343822). In the absence of actin, it also functions as a NADPH oxidase producing H(2)O(2) (PubMed:21864500, PubMed:26845023, PubMed:29343822). Acts as a cytoskeletal regulator that connects NEDD9 to intermediate filaments. Also acts as a negative regulator of apoptosi

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeletonEndosome membraneMidbody

VIAS BIOLÓGICAS (1)
Factors involved in megakaryocyte development and platelet production
EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
154.7 TPM
Sangue
152.9 TPM
Baço
149.7 TPM
Cervix Endocervix
135.5 TPM
Bladder
125.8 TPM
OUTRAS DOENÇAS (1)
autosomal dominant epilepsy with auditory features
HGNC:20619UniProt:Q8TDZ2
GRIN2AGlutamate receptor ionotropic, NMDA 2ACandidate gene tested inAltamente restrito
FUNÇÃO

Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed:20890276, PubMed:23933818, PubMed:23933819, PubMed:23933820, PubMed:24504326, PubMed:26875626, PubMed:26919761, PubMed:28242877, PubMed:36117210, PubMed:38538865, PubMed:8768735). NMDARs participate in synaptic plasticity for learning and memory formation by contributing to the slow phase of excita

LOCALIZAÇÃO

Cell projection, dendritic spineCell membraneSynapsePostsynaptic cell membraneCytoplasmic vesicle membrane

VIAS BIOLÓGICAS (1)
Assembly and cell surface presentation of NMDA receptors
MECANISMO DE DOENÇA

Epilepsy, focal, with speech disorder and with or without impaired intellectual development

An autosomal dominant, highly variable neurologic disorder. Features range from severe early-onset seizures associated with delayed psychomotor development, persistent speech difficulties, and intellectual disability to a more benign entity characterized by childhood onset of mild or asymptomatic seizures associated with transient speech difficulties followed by remission of seizures in adolescence and normal psychomotor development. The disorder encompasses several clinical entities, including Landau-Kleffner syndrome, epileptic encephalopathy with continuous spike and wave during slow-wave sleep, autosomal dominant rolandic epilepsy, intellectual disability and speech dyspraxia, and benign epilepsy with centrotemporal spikes.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
17.0 TPM
Cérebro - Hemisfério cerebelar
14.8 TPM
Cerebelo
12.7 TPM
Córtex cerebral
11.3 TPM
Brain Anterior cingulate cortex BA24
7.2 TPM
OUTRAS DOENÇAS (5)
early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutationdevelopmental and/or epileptic encephalopathy with spike-wave activation in sleeprolandic epilepsy-speech dyspraxia syndromeself-limited epilepsy with centrotemporal spikes
HGNC:4585UniProt:Q12879
GABRG2Gamma-aminobutyric acid receptor subunit gamma-2Candidate gene tested inAltamente restrito
FUNÇÃO

Gamma subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:14993607, PubMed:16412217, PubMed:23909897, PubMed:2538761, PubMed:25489750, PubMed:27864268, PubMed:29950725, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit in

LOCALIZAÇÃO

Postsynaptic cell membraneCell membraneCell projection, dendriteCytoplasmic vesicle membrane

VIAS BIOLÓGICAS (2)
GABA receptor activationSignaling by ERBB4
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 74

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE74 is an autosomal dominant form with onset in the first year of life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
20.3 TPM
Brain Frontal Cortex BA9
19.4 TPM
Cerebelo
15.3 TPM
Córtex cerebral
10.6 TPM
Brain Nucleus accumbens basal ganglia
7.7 TPM
OUTRAS DOENÇAS (7)
febrile seizures, familial, 8developmental and epileptic encephalopathy, 74obsolete Dravet syndromechildhood absence epilepsy
HGNC:4087UniProt:P18507
CRHCorticoliberinCandidate gene tested inTolerante
FUNÇÃO

Hormone regulating the release of corticotropin from pituitary gland (By similarity). Induces NLRP6 in intestinal epithelial cells, hence may influence gut microbiota profile (By similarity)

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (3)
G alpha (s) signalling eventsClass B/2 (Secretin family receptors)MECP2 regulates transcription of neuronal ligands
EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
12.2 TPM
Brain Anterior cingulate cortex BA24
9.8 TPM
Córtex cerebral
8.3 TPM
Hipotálamo
6.2 TPM
Cérebro - Amígdala
3.5 TPM
OUTRAS DOENÇAS (1)
autosomal dominant nocturnal frontal lobe epilepsy
HGNC:2355UniProt:P06850
CABP4Calcium-binding protein 4Candidate gene tested inTolerante
FUNÇÃO

Involved in normal synaptic function through regulation of Ca(2+) influx and neurotransmitter release in photoreceptor synaptic terminals and in auditory transmission. Modulator of CACNA1D and CACNA1F, suppressing the calcium-dependent inactivation and shifting the activation range to more hyperpolarized voltages (By similarity)

LOCALIZAÇÃO

CytoplasmPresynapse

MECANISMO DE DOENÇA

Cone-rod synaptic disorder, congenital non-progressive

A non-progressive retinal disorder characterized by stable low vision, nystagmus, photophobia, a normal or near-normal fundus appearance, and no night blindness.

OUTRAS DOENÇAS (2)
cone-rod synaptic disorder, congenital nonprogressiveautosomal dominant nocturnal frontal lobe epilepsy
HGNC:1386UniProt:P57796
SRPX2Sushi repeat-containing protein SRPX2Candidate gene tested inTolerante
FUNÇÃO

Acts as a ligand for the urokinase plasminogen activator surface receptor. Plays a role in angiogenesis by inducing endothelial cell migration and the formation of vascular network (cords). Involved in cellular migration and adhesion. Increases the phosphorylation levels of FAK. Interacts with and increases the mitogenic activity of HGF. Promotes synapse formation. May have a role in the perisylvian region, critical for language and cognitive development

LOCALIZAÇÃO

SecretedCytoplasmCell surfaceSynapse

MECANISMO DE DOENÇA

Rolandic epilepsy, impaired intellectual development, and speech dyspraxia, X-linked

A condition characterized by the association of rolandic seizures with oral and speech dyspraxia, and intellectual disability. Rolandic seizures occur during a period of significant brain maturation. During this time, dysfunction of neural network activities such as focal discharges may be associated with specific developmental disabilities resulting in specific cognitive impairments of language, visuo-spatial abilities or attention.

EXPRESSÃO TECIDUAL(Ubíquo)
Tecido adiposo
40.5 TPM
Fibroblastos
35.2 TPM
Adipose Visceral Omentum
34.4 TPM
Nervo tibial
29.5 TPM
Mama
21.9 TPM
OUTRAS DOENÇAS (4)
rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linkedrolandic epilepsy-speech dyspraxia syndromeself-limited epilepsy with centrotemporal spikesbilateral perisylvian polymicrogyria
HGNC:30668UniProt:O60687
GALGalanin peptidesDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Endocrine hormone of the central and peripheral nervous systems that binds and activates the G protein-coupled receptors GALR1, GALR2, and GALR3. This small neuropeptide may regulate diverse physiologic functions including contraction of smooth muscle of the gastrointestinal and genitourinary tract, growth hormone and insulin release and adrenal secretion

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (2)
G alpha (i) signalling eventsPeptide ligand-binding receptors
MECANISMO DE DOENÇA

Epilepsy, familial temporal lobe, 8

A focal form of epilepsy characterized by recurrent seizures that arise from foci within the temporal lobe. Seizures are usually accompanied by sensory symptoms, most often auditory in nature.

EXPRESSÃO TECIDUAL(Tecido-específico)
Pituitária
578.3 TPM
Hipotálamo
24.3 TPM
Cólon sigmoide
13.7 TPM
Esôfago - Muscular
7.3 TPM
Skin Not Sun Exposed Suprapubic
5.9 TPM
OUTRAS DOENÇAS (1)
familial temporal lobe epilepsy 8
HGNC:HGNC:4114UniProt:P22466
CHRNB2Neuronal acetylcholine receptor subunit beta-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti

LOCALIZAÇÃO

Synaptic cell membraneCell membrane

VIAS BIOLÓGICAS (3)
Highly calcium permeable nicotinic acetylcholine receptorsHighly sodium permeable postsynaptic acetylcholine nicotinic receptorsHighly calcium permeable postsynaptic nicotinic acetylcholine receptors
MECANISMO DE DOENÇA

Epilepsy, nocturnal frontal lobe, 3

An autosomal dominant focal epilepsy characterized by nocturnal seizures with hyperkinetic automatisms and poorly organized stereotyped movements.

OUTRAS DOENÇAS (2)
autosomal dominant nocturnal frontal lobe epilepsy 3autosomal dominant nocturnal frontal lobe epilepsy
HGNC:1962UniProt:P17787
CHRNA4Neuronal acetylcholine receptor subunit alpha-4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti

LOCALIZAÇÃO

Synaptic cell membraneCell membrane

VIAS BIOLÓGICAS (3)
Highly calcium permeable nicotinic acetylcholine receptorsHighly sodium permeable postsynaptic acetylcholine nicotinic receptorsHighly calcium permeable postsynaptic nicotinic acetylcholine receptors
MECANISMO DE DOENÇA

Epilepsy, nocturnal frontal lobe, 1

An autosomal dominant focal epilepsy characterized by nocturnal seizures with hyperkinetic automatisms and poorly organized stereotyped movements.

OUTRAS DOENÇAS (3)
autosomal dominant nocturnal frontal lobe epilepsy 1autosomal dominant nocturnal frontal lobe epilepsytobacco addiction, susceptibility to
HGNC:1958UniProt:P43681
KCNT1Potassium channel subfamily T member 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Sodium-activated K(+) channel (PubMed:37494189). Acts as an important mediator of neuronal membrane excitability (PubMed:37494189). Contributes to the delayed outward currents (By similarity). Regulates neuronal bursting in sensory neurons (By similarity). Contributes to synaptic development and plasticity (By similarity)

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 14

A rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay. This severe neurologic disorder is characterized by onset in the first 6 months of life of refractory focal seizures and arrest of psychomotor development. Ictal EEG shows discharges that arise randomly from various areas of both hemispheres and migrate from one brain region to another.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
94.7 TPM
Cérebro - Hemisfério cerebelar
80.1 TPM
Córtex cerebral
44.1 TPM
Brain Frontal Cortex BA9
30.4 TPM
Baço
20.2 TPM
OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy, 14autosomal dominant nocturnal frontal lobe epilepsy 5malignant migrating partial seizures of infancyautosomal dominant nocturnal frontal lobe epilepsy
HGNC:18865UniProt:Q5JUK3
LGI1Leucine-rich glioma-inactivated protein 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Regulates voltage-gated potassium channels assembled from KCNA1, KCNA4 and KCNAB1. It slows down channel inactivation by precluding channel closure mediated by the KCNAB1 subunit. Ligand for ADAM22 that positively regulates synaptic transmission mediated by AMPA-type glutamate receptors (By similarity). Plays a role in suppressing the production of MMP1/3 through the phosphatidylinositol 3-kinase/ERK pathway. May play a role in the control of neuroblastoma cell survival

LOCALIZAÇÃO

SecretedSynapseCytoplasmGolgi apparatusEndoplasmic reticulum

VIAS BIOLÓGICAS (1)
LGI-ADAM interactions
MECANISMO DE DOENÇA

Epilepsy, familial temporal lobe, 1

A focal form of epilepsy characterized by recurrent seizures that arise from foci within the temporal lobe. Seizures are usually accompanied by sensory symptoms, most often auditory in nature.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
21.0 TPM
Cerebelo
16.6 TPM
Brain Caudate basal ganglia
15.7 TPM
Brain Nucleus accumbens basal ganglia
14.9 TPM
Brain Frontal Cortex BA9
14.5 TPM
OUTRAS DOENÇAS (2)
epilepsy, familial temporal lobe, 1autosomal dominant epilepsy with auditory features
HGNC:6572UniProt:O95970
NPRL3GATOR1 complex protein NPRL3Disease-causing germline mutation(s) inRestrito
FUNÇÃO

As a component of the GATOR1 complex functions as an inhibitor of the amino acid-sensing branch of the mTORC1 pathway (PubMed:23723238, PubMed:29590090, PubMed:35338845). In response to amino acid depletion, the GATOR1 complex has GTPase activating protein (GAP) activity and strongly increases GTP hydrolysis by RagA/RRAGA (or RagB/RRAGB) within heterodimeric Rag complexes, thereby turning them into their inactive GDP-bound form, releasing mTORC1 from lysosomal surface and inhibiting mTORC1 signa

LOCALIZAÇÃO

Lysosome membrane

VIAS BIOLÓGICAS (1)
Amino acids regulate mTORC1
EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
54.0 TPM
Testículo
52.7 TPM
Sangue
52.6 TPM
Cerebelo
46.3 TPM
Nervo tibial
45.0 TPM
OUTRAS DOENÇAS (2)
epilepsy, familial focal, with variable foci 3familial focal epilepsy with variable foci
HGNC:14124UniProt:Q12980
NPRL2GATOR1 complex protein NPRL2Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Catalytic component of the GATOR1 complex, a multiprotein complex that functions as an inhibitor of the amino acid-sensing branch of the mTORC1 pathway (PubMed:23723238, PubMed:29590090, PubMed:35338845, PubMed:38006878). In response to amino acid depletion, the GATOR1 complex has GTPase activating protein (GAP) activity and strongly increases GTP hydrolysis by RagA/RRAGA (or RagB/RRAGB) within heterodimeric Rag complexes, thereby turning them into their inactive GDP-bound form, releasing mTORC1

LOCALIZAÇÃO

Lysosome membrane

VIAS BIOLÓGICAS (1)
Amino acids regulate mTORC1
EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
68.2 TPM
Cérebro - Hemisfério cerebelar
65.3 TPM
Pituitária
57.7 TPM
Ovário
45.2 TPM
Cervix Endocervix
44.3 TPM
OUTRAS DOENÇAS (2)
epilepsy, familial focal, with variable foci 2familial focal epilepsy with variable foci
HGNC:24969UniProt:Q8WTW4
CPA6Carboxypeptidase A6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in the proteolytic inactivation of enkephalins and neurotensin in some brain areas. May convert inactive angiotensin I into the biologically active angiotensin II (PubMed:18178555). Releases a C-terminal amino acid, with preference for large hydrophobic C-terminal amino acids and shows only very weak activity toward small amino acids and histidine (PubMed:20855895)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

OUTRAS DOENÇAS (4)
familial temporal lobe epilepsy 5febrile seizures, familial, 11familial mesial temporal lobe epilepsygeneralized epilepsy with febrile seizures plus
HGNC:17245UniProt:Q8N4T0
DEPDC5GATOR1 complex protein DEPDC5Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

As a component of the GATOR1 complex functions as an inhibitor of the amino acid-sensing branch of the mTORC1 pathway (PubMed:23723238, PubMed:25457612, PubMed:29590090, PubMed:29769719, PubMed:31548394, PubMed:35338845). In response to amino acid depletion, the GATOR1 complex has GTPase activating protein (GAP) activity and strongly increases GTP hydrolysis by RagA/RRAGA (or RagB/RRAGB) within heterodimeric Rag complexes, thereby turning them into their inactive GDP-bound form, releasing mTORC1

LOCALIZAÇÃO

Lysosome membraneCytoplasm, cytosolCytoplasm, perinuclear region

VIAS BIOLÓGICAS (1)
Amino acids regulate mTORC1
MECANISMO DE DOENÇA

Epilepsy, familial focal, with variable foci 1

An autosomal dominant form of epilepsy characterized by focal seizures arising from different cortical regions in different family members. Many patients have an aura and show automatisms during the seizures, whereas others may have nocturnal seizures. There is often secondary generalization. Some patients show abnormal interictal EEG, and some patients may have intellectual disability or autism spectrum disorders. Seizure onset usually occurs in the first or second decades, although later onset has been reported, and there is phenotypic variability within families. Penetrance of the disorder is incomplete.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
16.3 TPM
Testículo
13.5 TPM
Linfócitos
10.8 TPM
Baço
10.6 TPM
Cervix Ectocervix
10.5 TPM
OUTRAS DOENÇAS (5)
epilepsy, familial focal, with variable foci 1developmental and epileptic encephalopathy 111familial focal epilepsy with variable fociundetermined early-onset epileptic encephalopathy
HGNC:18423UniProt:O75140
KCNMA1Calcium-activated potassium channel subunit alpha-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Potassium channel activated by both membrane depolarization or increase in cytosolic Ca(2+) that mediates export of K(+) (PubMed:14523450, PubMed:29330545, PubMed:31152168). It is also activated by the concentration of cytosolic Mg(2+). Its activation dampens the excitatory events that elevate the cytosolic Ca(2+) concentration and/or depolarize the cell membrane. It therefore contributes to repolarization of the membrane potential. Plays a key role in controlling excitability in a number of sys

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (4)
cGMP effectsCa2+ activated K+ channelsAcetylcholine inhibits contraction of outer hair cellsSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Paroxysmal non-kinesigenic dyskinesia 3 with or without generalized epilepsy

An autosomal dominant neurologic disorder characterized by absence seizures, generalized tonic-clonic seizures, paroxysmal nonkinesigenic dyskinesia and involuntary dystonic or choreiform movements. Onset is usually in childhood. Patients may have seizures only, dyskinesia only, or both.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
43.8 TPM
Cólon sigmoide
36.4 TPM
Artéria tibial
30.3 TPM
Esôfago - Muscular
29.5 TPM
Esôfago - Junção
29.3 TPM
OUTRAS DOENÇAS (4)
Liang-Wang syndromegeneralized epilepsy-paroxysmal dyskinesia syndromecerebellar atrophy, developmental delay, and seizuresepilepsy, idiopathic generalized, susceptibility to, 16
HGNC:6284UniProt:Q12791
CHRNA2Neuronal acetylcholine receptor subunit alpha-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensiti

LOCALIZAÇÃO

Synaptic cell membraneCell membrane

VIAS BIOLÓGICAS (2)
Highly calcium permeable nicotinic acetylcholine receptorsHighly calcium permeable postsynaptic nicotinic acetylcholine receptors
MECANISMO DE DOENÇA

Epilepsy, nocturnal frontal lobe, 4

An autosomal dominant focal epilepsy characterized by nocturnal seizures associated with fear sensation, tongue movements, and nocturnal wandering, closely resembling nightmares and sleep walking.

OUTRAS DOENÇAS (2)
autosomal dominant nocturnal frontal lobe epilepsy 4autosomal dominant nocturnal frontal lobe epilepsy
HGNC:1956UniProt:Q15822

Medicamentos e terapias

NALUZOTANPhase 2

Mecanismo: Serotonin 1a (5-HT1a) receptor agonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

910 variantes patogênicas registradas no ClinVar.

🧬 SCN3A: NM_006922.4(SCN3A):c.603-1G>A ()
🧬 SCN3A: NM_006922.4(SCN3A):c.4349T>A (p.Ile1450Asn) ()
🧬 SCN3A: NM_006922.4(SCN3A):c.4200T>G (p.Phe1400Leu) ()
🧬 SCN3A: NM_006922.4(SCN3A):c.4456A>G (p.Thr1486Ala) ()
🧬 SCN3A: NM_006922.4(SCN3A):c.3616A>C (p.Asn1206His) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 1 medicamento · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Epilepsia parcial familiar

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1 papers (10 anos)

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Epilepsia parcial familiar.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Epilepsia parcial familiar

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Study of candidate gene cHRNA4 for familial epilepsy syndrome.
    European review for medical and pharmacological sciences· 2018· PMID 29630124mais citado
  2. Mosaic SCN1A mutations in familial partial epilepsy with antecedent febrile seizures.
    Genes Brain Behav· 2012· PMID 22151702recente
  3. Autosomal dominant nocturnal frontal lobe epilepsy: a genotypic comparative study of Japanese and Korean families carrying the CHRNA4 Ser284Leu mutation.
    J Hum Genet· 2011· PMID 21753767recente
  4. Familial partial epilepsy with variable foci: a new family with suggestion of linkage to chromosome 22q12.
    Epilepsia· 2010· PMID 20659149recente
  5. Malignant autosomal dominant frontal lobe epilepsy with repeated episodes of status epilepticus: successful treatment with vagal nerve stimulation.
    Epileptic Disord· 2010· PMID 20478764recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:309(Orphanet)
  2. MONDO:0017704(MONDO)
  3. Epilepsia(PCDT · Ministério da Saúde)
  4. GARD:2173(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55787290(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Epilepsia parcial familiar
Compêndio · Raras BR

Epilepsia parcial familiar

ORPHA:309 · MONDO:0017704
🇧🇷 Brasil SUS
Geral
Medicamentos
1 registrados
MedGen
UMLS
C5680862
Repurposing
14 candidatos
aminohydroxybutyric-acidcarbonic anhydrase inhibitor
diclofenamidesuccinimide antiepileptic
ethosuximideglutamate receptor antagonist
+11 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades